Discussions by the Ministry of Health, Labor and Welfare’s (MHLW) study group on the generic industry structure are reaching the last lap. Its final report - a draft of which will be presented later this month - is expected to…
HOME > TOP STORIES
TOP STORIES
-
BUSINESS GPCR Consortium, an International Partnership of Industry and Academia, Established: Ono
October 30, 2014
-
ORGANIZATION JPMA to Launch Compound Library Joint Purchasing Initiative; Full-Scale Purchasing to Begin in FY2015
October 29, 2014
-
BUSINESS Pfizer Japan Gearing Up for Reorganization in December, Pres. Umeda to Double as Head of New Unit
October 28, 2014
-
BUSINESS Japan Arm of Hengrui Medicine Files Campto Generic for Approval
October 27, 2014
-
REGULATORY Chuikyo Begins Discussions on Patient-Initiated Mixed-Care System
October 24, 2014
-
REGULATORY Online Document Filings for Healthcare Product Import/Export Possible from November
October 23, 2014
-
ORGANIZATION Japan CRO Association Nearing Remote Verification Agreement with Cancer Treatment Center
October 22, 2014
-
REGULATORY Health Ministry Eyes Future Genomic Data Registration at National Medical Centers
October 21, 2014
-
BUSINESS Astellas to End License Agreement with US Venture Company for AD Treatments
October 20, 2014
-
BUSINESS Bayer AG Aims to Achieve Japan Sales of 300 Billion Yen by 2017
October 17, 2014
-
REGULATORY NIBIO to Begin Drug Seed Optimization Project from FY2015
October 16, 2014
-
REGULATORY 4 Die after Taking SGLT-2 Inhibitors, Causality under Scrutiny
October 15, 2014
-
BUSINESS Parexel CEO Hails Rise of Partnership-Based Outsourcing in Japan
October 14, 2014
-
ACADEMIA St. Marianna Hospital Elbows Drug Makers to Reveal Detailing Costs Embedded in Drug Prices
October 10, 2014
-
BUSINESS GSK to Market Authorized Generics through Aspen Japan Unit
October 10, 2014
-
REGULATORY MOF Panel to Pitch Reference Pricing for Long-Listed Drugs, Price Cut in FY2015
October 9, 2014
-
BUSINESS Shire Japan Takes Aim at $500 Million Sales in 10 Years
October 8, 2014
-
BUSINESS Chugai, Roche Chiefs Were in Talks on Recent Deal Change from 2 Years Ago
October 7, 2014
-
BUSINESS JCR Pharmaceuticals Hopes to Make Japan’s First Cell Product into New Profit Pillar
October 6, 2014
-
ORGANIZATION JPMA Plans Disclosure of Recipients, Amount of Payments for R&D Outlays
October 3, 2014
ページ
Whenever an excellent employee or leader leaves, it’s a blow to your organization.The departure of staff is an inevitable part of business, but in a fiercely competitive recruitment landscape like Japan, employee retention is a priority.Not only does retaining staff…
The Japanese health ministry on December 22 approved a batch of medicines for additional indications, including Otsuka Pharmaceutical’s atypical antipsychotic Rexulti (brexpiprazole) and Zenyaku Kogyo’s anti-CD20 antibody Rituxan (rituximab).Rexulti is now newly indicated for the treatment of depression and depressive…
Authorized generic (AG) strategies taken by innovative drug makers might help soften the impact of generic competition in their businesses but such tactics might also accelerate the application of “G1”/“G2” price cuts for their off-patent brand-name medicines, a Jiho tally…
Japan’s health ministry announced new NHI prices to be applied in April under the FY2022 drug price revision in the official gazette on March 4, with the earlier application of so-called “G1” price cuts to be implemented for the first…